Novozymes Partners with Riffyn to Develop the Digital Future of Scientific Research

Riffyn, a provider of visual design and data analytics software, announces the formation of a multiyear partnership with Novozymes to deploy and develop Riffyn’s ground-breaking cloud-based software for experiment design and data analytics.  Riffyn’s Software-as-a-Service (SaaS) will be implemented progressively across Novozymes’ 1000-person global R&D organization to help support accelerated product development.

Siemens Investment Accelerates Launch of Riffyn’s Ground-breaking R&D Design Software

OAKLAND - July 6, 2016 - Riffyn, Inc. announces an investment by Siemens Venture Capital to accelerate the launch of its cloud-based research process design software. The investment brings Riffyn’s funding to $4.6M including lead investments from Bioeconomy Capital and O’Reilly Alphatech Ventures (OATV). Riffyn’s product delivers a step-change in the pace and quality of research and development in the life science, chemical and food industries – supporting organizations from early-stage discovery to manufacturing development and pre-clinical trials.